儿童医院药师万古霉素教育项目(VIPER)的实施
该文介绍某儿童医院开发并实施「药师万古霉素教育训练」(VIPER)项目,用于培训药师掌握儿童万古霉素治疗原则,包括AUC24导向给药和MIPD工具,以支持药师主导的治疗药物监测服务。自2020年实施以来超100名药师受训,89%(96/108)认为VIPER是传达机构指南更新的有效策略,84%(91/108)表示对儿童万古霉素剂量调整更有信心,课后知识中位分每年≥85%。
要点
- VIPER为年度正式教育项目,药师需完成核心培训后才能独立管理儿童TDM。
- 培训涵盖AUC24导向给药和商用MIPD工具的使用。
- 药师对VIPER满意度高,课后知识中位分每年≥85%。
核心结论
- VIPER作为正式年度教育项目在本院成功实施,支持药师主导的儿童万古霉素TDM服务,药师满意度高并认可其教育效果。
研究设计与样本
- 单中心儿童医院项目实施描述,包括VIPER核心项目、年度维持项目和年度药师感知调查。
主要发现
- 自2020年实施以来超过100名药师接受培训。
- 89%(96/108)同意或强烈同意VIPER是传达机构指南更新的有效策略。
- 84%(91/108)同意或强烈同意VIPER后对儿童万古霉素剂量调整更有信心。
- 课后知识评估显示每年中位分≥85%。
关键数值与推荐
- 药师需完成VIPER核心项目后才能独立管理儿童TDM。
- VIPER维持项目每年开展以维持和扩展知识。
临床怎么用
- 儿童医院可借鉴VIPER模式开展药师培训,以支持AUC24导向给药和MIPD在儿童万古霉素TDM中的应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Pharmacists play a vital role in supporting the safe and efficacious use of vancomycin in children. However, vancomycin dosing in children is challenging, and recent recommendations for implementation of 24-hour area under the curve (AUC24)-based dosing and model informed precision dosing (MIPD) approaches introduce additional complexity. Herein, we describe the development and implementation of a "VancomycIn per Pharmacy Education tRaining" (VIPER) program that supports a pharmacy-led vancomycin therapeutic drug monitoring (TDM) service at a children's hospital. SUMMARY: Our children's hospital implemented a formal VIPER program to educate and evaluate the competency of pharmacists on vancomycin therapeutic principles in children, including AUC24-based dosing and use of a commercially available MIPD tool. Pharmacists were required to complete the VIPER core program prior to managing TDM independently in children. VIPER maintenance programs were delivered annually to sustain and expand knowledge. Pharmacists' perceptions of VIPER were captured annually via survey. Since implementation of VIPER in 2020, over 100 pharmacists have received training. Overall, pharmacists rated the VIPER program highly, with 89% (96/108) agreeing or strongly agreeing that VIPER was an effective strategy for delivering institutional guideline updates and 84% (91/108) agreeing or strongly agreeing they felt more confident in vancomycin dose adjustments in children after VIPER. Competency assessment also demonstrated that pharmacist postcourse knowledge was high (a median score of ≥85% for each year). CONCLUSION: VIPER, a formal, yearly educational program, was successfully implemented at our hospital to help support a pharmacist-led vancomycin TDM service in children. The pharmacists reported high satisfaction with VIPER and agreed the program was a successful format for delivering education and improving skills.
引用
- Bio L, Gaskari S, Schwenk HT, et al. Implementation of the VancomycIn per Pharmacy Education tRaining (VIPER) program for pharmacists at a children's hospital. Am J Health Syst Pharm. 2026. PMID: 40465837. doi:10.1093/ajhp/zxaf142
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。